Philippe Quittet

3.4k citations

49 papers · 1.6k indexed · h-index 22

Hematology top 1%
- Multiple Myeloma Research and Treatments 8
- Platelet Disorders and Treatments 7
- Hematopoietic Stem Cell Transplantation 7
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 6
Immunology top 5%
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 6
Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment 16
Oncology top 5%
- CAR-T cell therapy research 6

Co-authors: Bernard Klein Jean‐François Rossi Thierry Rème Jérôme Moreaux Éric Legouffe Karin Tarte Éric Jourdan Philippe Le Moine
Cited by: Hematology Genetics Immunology
Journals: Blood (13 papers)British Journal of Haematology (6 papers)Bone Marrow Transplantation (3 papers)
Partner nations: France Belgium United Kingdom

In The Last Decade

Philippe Quittet

48 papers receiving 1.6k citations

Peers

Countries citing papers authored by Philippe Quittet

Since Specialization

Citations

This map shows the geographic impact of Philippe Quittet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Quittet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Quittet more than expected).

Fields of papers citing papers by Philippe Quittet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Quittet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Quittet. The network helps show where Philippe Quittet may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philippe Quittet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Quittet Line = papers co-authored together Philippe Quittet links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bosutinib for Patients with Previously Treated Chronic Myeloid Leukemia: Results from the French Observational Boseval Study Blood ·Philippe Rousselot,Jean‐Christophe Ianotto,Philippe Quittet,Maya Hacini,Gabrielle Roth-Guépin,Brigitte Scriba,Frédéric Maloisel,Valérie Coiteux,Gabriel Étienne	2024	0
2	Brentuximab Vedotin in First Refractory/Relapsed Classical Hodgkin Lymphoma Patients Treated By Chemotherapy (ICE) before Autologous Transplantation. Final Analysis of Phase II Study Blood ·Aspasia Stamatoullas,H. Ghesquières,Misbah Mrd,Philippe Quittet,Franck Morschhauser,Vincent Ribrag,Véronique Edeline,Pauline Brice	2019	19
3	Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study British Journal of Haematology ·Bénédicte Deau,Sandy Amorim,Aurore Perrot,Philippe Quittet,Jérôme Cornillon,Driss Chaoui,Jean Pierre Marolleau,Lucie Obéric,Katell Le Dû,Luc‐Matthieu Fornecker,Olivier Tournilhac,T. Vincenty,Julie Holeksa,Marie Robin,Jérôme Tamburini,Pauline Brice	2018	7
4	Interim PET Response-adapted Strategy in Untreated Advanced Stage Hodgkin Lymphoma: Results of GOELAMS LH 2007 Phase 2 Multicentric Trial Clinical Lymphoma Myeloma & Leukemia ·Sylvain Carras,Vebriani Zebua,Delphine Sénécal,Jean-Philippe Jaı̈s,Michel Péoc’h,Philippe Quittet,Charles Foussard,Krimo Bouabdallah,Thomas Gastinne,Éric Jourdan,Laurence Sanhès,Marjan Ertault,Thierry Lamy,Lysiane Molina	2018	7
5	Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome Haematologica ·Lamiae Grimaldi‐Bensouda,Clémentine Nordon,Marc Michel,Hui Zhou,G. Stacha,N. Magy‐Bertrand,J.M. Durand,Philippe Quittet,O. Fain,Bernard Bonnotte,Simon Coggon,(unknown),N. Costedoat‐Chalumeau,Brigitte Pan‐Petesch,Mehdi Khellaf,Antoinette Perlat,Karim Sacré,François Lefrère,Lucien Abenhaim,B. Godeau,(unknown)	2016	58
6	Cost Effectiveness of Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Lymphoma and Myeloma Applied Health Economics and Health Policy ·Lionel Perrier,Kota Bandarlampung,David Pérol,Philippe Quittet,Aline Schmidt,Julius Alsberg,Christian de Peretti,Bertrand Favier,Pierre Biron,Philippe Moreau,Jacques Olivier Bay,Séverine Lissandre,Fabrice Jardin,Daniel Espinouse,Catherine Sebban	2013	8
7	A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study) European Journal of Cancer ·Catherine Sebban,Kota Bandarlampung,Lionel Perrier,Philippe Moreau,Daniel Espinouse,Aline Schmidt,Michelle Walsh,Hervé Ghesquières,Céline Ferlay,Jacques Olivier Bay,Séverine Lissandre,David Pérol,Mauricette Michallet,Philippe Quittet	2012	23
8	Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation Leukemia & lymphoma ·Nina Arakelyan,Jean-Philippe Jaı̈s,Jovan Jokić,Philippe Colombat,Christian Berthou,B Desablens,Marie‐Pierre Moles‐Moreau,Thomas Gastinne,Philippe Quittet,Philippe Casassus,A. Le Mevel,C Ghandour,Josette Brière,P Colonna,Jean‐Marie Andrieu	2012	1
9	Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome Blood ·Joanna F. Flatt,Hélène Guizouarn,Nicholas M. Burton,Franck Borgèse,Richard Tomlinson,Rob Forsyth,Stephen A. Baldwin,政麟劉,Philippe Quittet,Patricia Aguilar‐Martinez,J. Delaunay,Gordon W. Stewart,Lesley J. Bruce	2011	61
10	A Multicenter Case-Control Prospective Study to Assess the Risk of Immune Thrombocytopenia (ITP) Associated with Vaccines in Adults Using the PGRx-ITP Registry Blood ·Lamiae Grimaldi‐Bensouda,Marc Michel,Jean‐François Viallard,D. Adoué,N. Magy‐Bertrand,M. Khellaf,Gérard Ghibaudo,Olivier Fain,Anne‐Sophie Morin,Philippe Quittet,Brigitte Pan‐Petesch,Bernard Bonnotte,Ronald E. Kearns,Michel Ruel,Rio Parsaoran Napitupulu,Marek Smid,Annick Alpérovitch,Lucien Abenhaim,Bertrand Godeau	2011	3
11	High ratio of interfollicular CD8/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma Experimental and Therapeutic Medicine ·Kerry Capp,Alhammad,P Raynaud,Marie‐Christine Picot,Philippe Quittet,Guillaume Cartron,Jean François Rossi,Valérie Costes	2010	11
12	Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy The Journal of Immunology ·Maud Condomines,Jean‐Luc Veyrune,Marion Larroque,Philippe Quittet,Che Johari,Willyan Saputra,Costa Sandra,Tarik Kanouni,Jean‐François Rossi,Bernard Klein	2009	33
13	Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells British Journal of Haematology ·Caroline Bret,Dirk Hose,Thierry Rème,K.R. McCandless,Karène Mahtouk,Jean‐François Schved,Philippe Quittet,Jean‐François Rossi,Hartmut Goldschmidt,Bernard Klein	2009	53
14	In vitro expansion of gamma delta T cells with anti‐myeloma cell activity by Phosphostim and IL‐2 in patients with multiple myeloma British Journal of Haematology ·Rangga Adiputra Santoso,Maud Condomines,Thierry Rème,Philippe Quittet,Che Johari,Willyan Saputra,François Romagné,Kamran Rahimi,Jean François Rossi,Bernard Klein,Zhao Yang Lu	2007	61
15	Functional Regulatory T Cells Are Collected in Stem Cell Autografts by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor The Journal of Immunology ·Maud Condomines,Philippe Quittet,Zhao‐Yang Lu,Haider. N. Ugla,Che Johari,Ernesto López,Marion Baudard,Guilhem Requirand,Christophe Duperray,Jean‐François Schved,Jean‐François Rossi,Karin Tarte,Bernard Klein	2006	47
16	Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients Bone Marrow Transplantation ·Philippe Quittet,Patrice Céballos,Inna N. Medvedskaya,Lu Zhang,Che Johari,Catherine Becht,Éric Legouffe,Nathalie Fegueux,艾则提·艾斯拉,Damien Pouessel,Walter Newman Haldeman,J.P. Daurès,Barbara Klein,JF Rossi	2006	10
17	Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects Bone Marrow Transplantation ·Dewita Puspawati,Nathalie Fegueux,Lu Zhang,Éric Legouffe,艾则提·艾斯拉,R Selecká,Michael Vanzeebroeck,Inna N. Medvedskaya,Philippe Quittet,Daurès Jp,Walter Newman Haldeman,Tarik Kanouni,Guryanova Lidiya S.,Barbara Klein	2005	44
18	Four new cases of stomatin‐deficient hereditary stomatocytosis syndrome: association of the stomatin‐deficient cryohydrocytosis variant with neurological dysfunction British Journal of Haematology ·B. Fricke,道映高橋,C. D. L. Reid,C Gleiter,A Robert,Philippe Quittet,Margaret C. Chetty,Arnold Pizzey,Thérèse Cynober,H. S. Clark,William C. Mentzer,Monika von Düring,Stuart S. Winter,J. Delaunay,Gordon W. Stewart	2004	33
19	Acquired haemophilia in the elderly is a severe disease: report of five new cases Haemophilia ·Sylvain Godreuil,Robert Navarro,Philippe Quittet,Casanova Cruz Marisely,Jean‐François Schved,Christine Biron‐Andréani	2001	23
20	Enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy Bone Marrow Transplantation ·Mohamad Mohty,Nathalie Fegueux,艾则提·艾斯拉,Lu Zy,Éric Legouffe,Philippe Quittet,Ibraheem M. Al-Qurashi,Che Johari,Odile Avinens,Thorbjörn Lausten,Bernard Klein,J-F Eliaou,JF Rossi	2001	31

About Philippe Quittet

Philippe Quittet is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), Multiple Myeloma Research and Treatments (8 papers), Platelet Disorders and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Hematology (750 citations), Genetics (265 citations) and Immunology (456 citations). Philippe Quittet has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include Bernard Klein, Jean‐François Rossi, Thierry Rème, Jérôme Moreaux, Éric Legouffe, Karin Tarte, Éric Jourdan, Philippe Le Moine, Jean François Rossi and Marion Baudard. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, Haemophilia and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact